{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T08:08:55Z","timestamp":1784448535843,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s40261-025-01425-y","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T01:22:36Z","timestamp":1739841756000},"page":"137-150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Age-Specific Plasma Concentration, Efficacy and Safety of Ciprofol (Cipepofol) for Induction and Maintenance of General Anesthesia in Pediatric Patients Undergoing Elective Surgery: A Single-Arm Prospective, Pragmatic Trial"],"prefix":"10.1007","volume":"45","author":[{"given":"Zheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuochao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuibing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangquan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"issue":"5","key":"1425_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S2213-2600(17)30116-9","volume":"5","author":"W Habre","year":"2017","unstructured":"Habre W, Disma N, Virag K, Becke K, Hansen TG, J\u00f6hr M, et al. Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe. Lancet Respir Med. 2017;5(5):412\u201325.","journal-title":"Lancet Respir Med"},{"issue":"9743","key":"1425_CR2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0140-6736(10)61193-2","volume":"376","author":"BS von Ungern-Sternberg","year":"2010","unstructured":"von Ungern-Sternberg BS, Boda K, Chambers NA, Rebmann C, Johnson C, Sly PD, et al. Risk assessment for respiratory complications in paediatric anaesthesia: a prospective cohort study. Lancet (London, England). 2010;376(9743):773\u201383.","journal-title":"Lancet (London, England)."},{"issue":"5","key":"1425_CR3","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1213\/ANE.0b013e3182501b04","volume":"115","author":"MC Smith","year":"2012","unstructured":"Smith MC, Williamson J, Yaster M, Boyd GJ, Heitmiller ES. Off-label use of medications in children undergoing sedation and anesthesia. Anesth Analg. 2012;115(5):1148\u201354.","journal-title":"Anesth Analg"},{"issue":"5","key":"1425_CR4","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1213\/00000539-199705000-00007","volume":"84","author":"PJ Davis","year":"1997","unstructured":"Davis PJ, Lerman J, Suresh S, McGowan FX, Cot\u00e9 CJ, Landsman I, et al. A randomized multicenter study of remifentanil compared with alfentanil, isoflurane, or propofol in anesthetized pediatric patients undergoing elective strabismus surgery. Anesth Analg. 1997;84(5):982\u20139.","journal-title":"Anesth Analg"},{"issue":"9","key":"1425_CR5","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1021\/acs.jmedchem.7b00254","volume":"60","author":"L Qin","year":"2017","unstructured":"Qin L, Ren L, Wan S, Liu G, Luo X, Liu Z, et al. Design, synthesis, and evaluation of novel 2,6-disubstituted phenol derivatives as general anesthetics. J Med Chem. 2017;60(9):3606\u201317.","journal-title":"J Med Chem"},{"key":"1425_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.830791","volume":"13","author":"J Liao","year":"2022","unstructured":"Liao J, Li M, Huang C, Yu Y, Chen Y, Gan J, et al. Pharmacodynamics and pharmacokinetics of HSK3486, a novel 2,6-disubstituted phenol derivative as a general anesthetic. Front Pharmacol. 2022;13: 830791.","journal-title":"Front Pharmacol"},{"key":"1425_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.105904","volume":"164","author":"Y Teng","year":"2021","unstructured":"Teng Y, Ou M, Wang X, Zhang W, Liu X, Liang Y, et al. Efficacy and safety of ciprofol for the sedation\/anesthesia in patients undergoing colonoscopy: phase IIa and IIb multi-center clinical trials. Eur J Pharm Sci. 2021;164: 105904.","journal-title":"Eur J Pharm Sci"},{"issue":"342","key":"1425_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d1110","volume":"15","author":"L Jalota","year":"2011","unstructured":"Jalota L, Kalira V, George E, Shi YY, Hornuss C, Radke O, et al. Prevention of pain on injection of propofol: systematic review and meta-analysis. BMJ (Clinical research ed). 2011;15(342): d1110.","journal-title":"BMJ (Clinical research ed)."},{"issue":"1","key":"1425_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/bcp.14363","volume":"87","author":"Y Bian","year":"2021","unstructured":"Bian Y, Zhang H, Ma S, Jiao Y, Yan P, Liu X, et al. Mass balance, pharmacokinetics and pharmacodynamics of intravenous HSK3486, a novel anaesthetic, administered to healthy subjects. Br J Clin Pharmacol. 2021;87(1):93\u2013105.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"1425_CR10","first-page":"1607","volume":"26","author":"X Wang","year":"2022","unstructured":"Wang X, Wang X, Liu J, Zuo YX, Zhu QM, Wei XC, et al. Effects of ciprofol for the induction of general anesthesia in patients scheduled for elective surgery compared to propofol: a phase 3, multicenter, randomized, double-blind, comparative study. Eur Rev Med Pharmacol Sci. 2022;26(5):1607\u201317.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"1425_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/bcpt.13761","volume":"131","author":"J Li","year":"2022","unstructured":"Li J, Wang X, Liu J, Wang X, Li X, Wang Y, et al. Comparison of ciprofol (HSK3486) versus propofol for the induction of deep sedation during gastroscopy and colonoscopy procedures: A multi-centre, non-inferiority, randomized, controlled phase 3 clinical trial. Basic Clin Pharmacol Toxicol. 2022;131(2):138\u201348.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"6","key":"1425_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/EJA.0000000000001799","volume":"40","author":"P Liang","year":"2023","unstructured":"Liang P, Dai M, Wang X, Wang D, Yang M, Lin X, et al. Efficacy and safety of ciprofol vs propofol for the induction and maintenance of general anaesthesia: A multicentre, single-blind, randomised, parallel-group, phase 3 clinical trial. Eur J Anaesthesiol. 2023;40(6):399\u2013406.","journal-title":"Eur J Anaesthesiol"},{"issue":"10","key":"1425_CR13","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1097\/CCM.0000000000005920","volume":"51","author":"Y Liu","year":"2023","unstructured":"Liu Y, Peng Z, Liu S, Yu X, Zhu D, Zhang L, et al. Efficacy and safety of ciprofol sedation in ICU patients undergoing mechanical ventilation: a multicenter, single-blind, randomized, noninferiority trial. Crit Care Med. 2023;51(10):1318\u201327.","journal-title":"Crit Care Med"},{"issue":"9","key":"1425_CR14","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/CM9.0000000000001912","volume":"135","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yu X, Zhu D, Zeng J, Lin Q, Zang B, et al. Safety and efficacy of ciprofol vs. propofol for sedation in intensive care unit patients with mechanical ventilation: a multi-center, open label, randomized, phase 2 trial. Chin Med J. 2022;135(9):1043\u201351.","journal-title":"Chin Med J"},{"issue":"2","key":"1425_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.1066","volume":"11","author":"G Duan","year":"2023","unstructured":"Duan G, Lan H, Shan W, Wu Y, Xu Q, Dong X, et al. Clinical effect of different doses of ciprofol for induction of general anesthesia in elderly patients: A randomized, controlled trial. Pharmacol Res Perspect. 2023;11(2): E01066.","journal-title":"Pharmacol Res Perspect"},{"issue":"12","key":"1425_CR16","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/EJA.0000000000001759","volume":"39","author":"YY Ding","year":"2022","unstructured":"Ding YY, Long YQ, Yang HT, Zhuang K, Ji FH, Peng K. Efficacy and safety of ciprofol for general anaesthesia induction in elderly patients undergoing major noncardiac surgery: a randomised controlled pilot trial. Eur J Anaesthesiol. 2022;39(12):960\u20133.","journal-title":"Eur J Anaesthesiol"},{"key":"1425_CR17","unstructured":"ICH Topic E 11 Clinical Investigation of Medicinal Products in the Paediatric Population 2001 [cited 2001 Jan 1]; Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/e-11-clinical-investigation-medicinal-products-paediatric-population-step-5_en.pdf."},{"key":"1425_CR18","unstructured":"ICH guideline S11 on nonclinical safety testing in support of development of paediatric pharmaceuticals. 2020 [cited 31 March 2020]; Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-s11-nonclinical-safety-testing-support-development-paediatric-pharmaceuticals-step-5_en.pdf."},{"issue":"3","key":"1425_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/bdd.2368","volume":"44","author":"M Zhang","year":"2023","unstructured":"Zhang M, Yu Z, Liu H, Wang X, Li H, Yao X, et al. Model-informed drug development: The mechanistic HSK3486 physiologically based pharmacokinetic model informing dose decisions in clinical trials of specific populations. Biopharm Drug Disposit. 2023;44(3):259\u201373.","journal-title":"Biopharm Drug Disposit"},{"issue":"4","key":"1425_CR20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00004714-199008000-00003","volume":"10","author":"DA Chernik","year":"1990","unstructured":"Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, et al. Validity and reliability of the Observer\u2019s Assessment of Alertness\/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10(4):244\u201351.","journal-title":"J Clin Psychopharmacol"},{"key":"1425_CR21","doi-asserted-by":"publisher","first-page":"1260599","DOI":"10.3389\/fphar.2023.1260599","volume":"14","author":"J Tao","year":"2023","unstructured":"Tao J, Liu S, Zhao YY, Qi L, Yan P, Wu N, et al. Pharmacokinetics, pharmacodynamics, and safety of ciprofol emulsion in Chinese subjects with normal or impaired renal function. Front Pharmacol. 2023;14:1260599.","journal-title":"Front Pharmacol"},{"key":"1425_CR22","unstructured":"Introductory Guide MedDRA Version 24.0. 2021 [cited March, 2021]; Available from: https:\/\/admin.new.meddra.org\/sites\/default\/files\/guidance\/file\/intguide_%2024_0_English.pdf"},{"key":"1425_CR23","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE v5.0). 2017 [cited 27 Nov 2017]; Available from: https:\/\/ ctep. cancer. gov\/ proto colDe velop ment\/ electronic_ appli catio ns\/ docs\/ CTCAE_ v5_ Quick_ Refer ence_ 5x7. pdf"},{"issue":"5","key":"1425_CR24","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1177\/1740774515598334","volume":"12","author":"RM Califf","year":"2015","unstructured":"Califf RM, Sugarman J. Exploring the ethical and regulatory issues in pragmatic clinical trials. Clinical trials (London, England). 2015;12(5):436\u201341.","journal-title":"Clinical trials (London, England)."},{"issue":"3","key":"1425_CR25","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/2168479018763591","volume":"52","author":"NA Dreyer","year":"2018","unstructured":"Dreyer NA. Advancing a framework for regulatory use of real-world evidence: when real is reliable. Therap Innov Regul Sci. 2018;52(3):362\u20138.","journal-title":"Therap Innov Regul Sci"},{"key":"1425_CR26","unstructured":"Chinese Society of Anesthesiology Pediatric Anesthesiology Group; Chinese Society of Anesthesiology Organ Transplantation Anesthesiology Group; Chinese Society of Cardiovascular Anesthesiology Day Surgery Anesthesia Group. [Chinese expert consensus on pediatric anesthesia assessment and perioperative risk prediction (2024 edition)]. Zhonghua yi xue za zhi. 2024;104(29):2688\u2013700."},{"issue":"1","key":"1425_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1399-6576.2004.00260.x","volume":"48","author":"A Ekman","year":"2004","unstructured":"Ekman A, Lindholm ML, Lennmarken C, Sandin R. Reduction in the incidence of awareness using BIS monitoring. Acta Anaesthesiol Scand. 2004;48(1):20\u20136.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"9","key":"1425_CR28","first-page":"Cd003843","volume":"9","author":"SR Lewis","year":"2019","unstructured":"Lewis SR, Pritchard MW, Fawcett LJ, Punjasawadwong Y. Bispectral index for improving intraoperative awareness and early postoperative recovery in adults. The Cochrane Database Syst Rev. 2019;9(9):Cd003843.","journal-title":"The Cochrane Database Syst Rev"},{"issue":"1","key":"1425_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12887-022-03180-x","volume":"22","author":"B Schultz","year":"2022","unstructured":"Schultz B, Schultz M, Boehne M, Dennhardt N. EEG monitoring during anesthesia in children aged 0 to 18 months: amplitude-integrated EEG and age effects. BMC Pediatr. 2022;22(1):156.","journal-title":"BMC Pediatr"},{"key":"1425_CR30","first-page":"15","volume":"1","author":"AU Lekmanov","year":"2007","unstructured":"Lekmanov AU, Karpovich SV, Mikha\u012dlov EV, Suvorov SG. Assessment of a hypnotic component on the basis of BIS monitoring during balanced anesthesia in children. Anesteziol Reanimatol. 2007;1:15\u20136.","journal-title":"Anesteziol Reanimatol"},{"issue":"1","key":"1425_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1067\/mge.2002.120386","volume":"55","author":"R Kaddu","year":"2002","unstructured":"Kaddu R, Bhattacharya D, Metriyakool K, Thomas R, Tolia V. Propofol compared with general anesthesia for pediatric GI endoscopy: is propofol better? Gastrointest Endosc. 2002;55(1):27\u201332.","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"1425_CR32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1213\/ANE.0000000000006196","volume":"136","author":"H van Dijk","year":"2023","unstructured":"van Dijk H, Hendriks MP, van Eck-Smaling MM, van Wolfswinkel L, van Loon K. Age-stratified propofol dosage for pediatric procedural sedation and analgesia. Anesth Analg. 2023;136(3):551\u20138.","journal-title":"Anesth Analg"},{"issue":"11","key":"1425_CR33","doi-asserted-by":"publisher","first-page":"e546","DOI":"10.1097\/PCC.0000000000002730","volume":"22","author":"M Takeuchi","year":"2021","unstructured":"Takeuchi M, Nemoto S, Suzuki Y, Takahashi N, Takenaka N, Takata A, et al. Age-specific dose regimens of dexmedetomidine for pediatric patients in intensive care following elective surgery: a phase 3, multicenter, open-label clinical trial in Japan. Pediatric Crit Care Med. 2021;22(11):e546\u201357.","journal-title":"Pediatric Crit Care Med"},{"issue":"1","key":"1425_CR34","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1213\/ane.0b013e31818c0dac","volume":"108","author":"D Stamenkovic","year":"2009","unstructured":"Stamenkovic D, Kangrga I, Karanikolas M. Caution is necessary when dexmedetomidine is used off-label, especially when combined with other sedatives. Anesth Analg. 2009;108(1):380\u20132.","journal-title":"Anesth Analg"},{"issue":"7","key":"1425_CR35","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/pan.13397","volume":"28","author":"AG Tsiotou","year":"2018","unstructured":"Tsiotou AG, Malisiova A, Kouptsova E, Mavri M, Anagnostopoulou M, Kalliardou E. Dexmedetomidine for the reduction of emergence delirium in children undergoing tonsillectomy with propofol anesthesia: a double-blind, randomized study. Paediatr Anaesth. 2018;28(7):632\u20138.","journal-title":"Paediatr Anaesth"},{"issue":"6","key":"1425_CR36","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/aas.12292","volume":"58","author":"L Sun","year":"2014","unstructured":"Sun L, Guo R, Sun L. Dexmedetomidine for preventing sevoflurane-related emergence agitation in children: a meta-analysis of randomized controlled trials. Acta Anaesthesiol Scand. 2014;58(6):642\u201350.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"4","key":"1425_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123728","volume":"10","author":"M Zhu","year":"2015","unstructured":"Zhu M, Wang H, Zhu A, Niu K, Wang G. Meta-analysis of dexmedetomidine on emergence agitation and recovery profiles in children after sevoflurane anesthesia: different administration and different dosage. PLoS ONE. 2015;10(4): e0123728.","journal-title":"PLoS ONE"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-025-01425-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-025-01425-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-025-01425-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T16:03:10Z","timestamp":1741017790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-025-01425-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1425"],"URL":"https:\/\/doi.org\/10.1007\/s40261-025-01425-y","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"28 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors did not receive support from any organization for the submitted research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Yong Cao, Junxia Chen and Yiwei Mao are employees of Xizang Haisco Pharmaceutical Co., Ltd. The remaining authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The data that support the findings of this study are available on reasonable request from the corresponding author. The data are not publicly available due to ethical and privacy considerations to protect the confidentiality of patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Materials"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the ethical committee of Hunan Children\u2019s Hospital (approval number HNSETYYLL2023016).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was obtained from a parent or a legal proxy.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Zheng Chen, Tuochao Peng, Shuangquan Qu, Yong Cao and Junxia Chen contributed to the study conception and design. Material preparation, data collection and interpretation were performed by Zheng Chen, Tuochao Peng, Shuibing Zhang, Qiaoyun Yang, Junxia Chen and Yiwei Mao; furthermore, Zheng Chen, Shuangquan Qu, Yong Cao, Junxia Chen and Yiwei Mao were in charge of statistical analysis. The first draft of the manuscript was written by Zheng Chen, Tuochao Peng, Shuibing Zhang, Qiaoyun Yang and Junxia Chen, and all authors commented on previous versions of the manuscript. All authors read and approved the final version of the submitted manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}